Authors: Basu, S Nagy, JA Pal, S Vasile, E Eckelhoefer, IA Bliss, VS Manseau, EJ Dasgupta, PS Dvorak, HF Mukhopadhyay, D

Citation: S. Basu et al., The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor, NAT MED, 7(5), 2001, pp. 569-574

Authors: Sundberg, C Nagy, JA Brown, LF Feng, D Eckelhoefer, IA Manseau, EJ Dvorak, AM Dvorak, HF

Citation: C. Sundberg et al., Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery, AM J PATH, 158(3), 2001, pp. 1145-1160

Authors: Pettersson, A Nagy, JA Brown, LF Sundberg, C Morgan, E Jungles, S Carter, R Krieger, JE Manseau, EJ Harvey, VS Eckelhoefer, IA Feng, D Dvorak, AM Mulligan, RC Dvorak, HF

Citation: A. Pettersson et al., Heterogeneity of the angiogenic response induced in different normal adulttissues by vascular permeability factor/vascular endothelial growth factor, LAB INV, 80(1), 2000, pp. 99-115

Authors: Feng, D Nagy, JA Brekken, RA Pettersson, A Manseau, EJ Pyne, K Mulligan, R Thorpe, PE Dvorak, HF Dvorak, AM

Citation: D. Feng et al., Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors, J HIST CYTO, 48(4), 2000, pp. 545-555